Bellus Stock Analysis

BLU
 Stock
  

USD 11.93  0.13  1.10%   

The newest price gain of Bellus Health could raise concerns from private investors as the firm is trading at a share price of 11.93 on 314,472 in volume. The company directors and management may have good odds in positioning the firm resources to exploit market volatility in September. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.59. This high volatility is attributed to the latest market swings and not-so-good earnings reports for some of the Bellus Health partners.
Continue to Trending Equities.
  
The Bellus Health stock analysis report makes it easy to digest most publicly released information about Bellus Health and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Bellus Stock analysis module also helps to analyze the Bellus Health price relationship with some important fundamental indicators such as market cap and management efficiency.

Bellus Stock Analysis Notes

About 90.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.85. Bellus Health had not issued any dividends in recent years. The entity had a split on the 19th of August 2019. BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough and other cough hypersensitivity indications. The company was incorporated in 1993 and is based in Laval, Canada. Bellus Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 40 people. For more info on Bellus Health please contact Mark Levy at 450 680 4500 or go to https://www.bellushealth.com.

Bellus Health Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Bellus Health's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Bellus Health or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Bellus Health appears to be risky and price may revert if volatility continues
The company reported the last year's revenue of 16 K. Reported Net Loss for the year was (69.83 M) with profit before taxes, overhead, and interest of 16 K.
Bellus Health has about 233.97 M in cash with (60.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.19.
Bellus Health has a frail financial position based on the latest SEC disclosures
Over 90.0% of the company shares are held by institutions such as insurance companies
Latest headline from stockhouse.com: 2022-08-10 TSXBLU Press Release BELLUS Health Inc. - Stockhouse

Bellus Health Upcoming and Recent Events

Earnings reports are used by Bellus Health to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Bellus Health previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report24th of February 2022
Next Financial Report9th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End24th of February 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Bellus Health SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Bellus Health prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Bellus Health investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Bellus Health specific information freely available to individual and institutional investors to make a timely investment decision.

Bellus Health Thematic Classifications

In addition to having Bellus Health stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Pharmaceutical Products
USA Equities from Pharmaceutical Products industry as classified by Fama & French

Bellus Market Capitalization

The company currently falls under 'Mid-Cap' category with total capitalization of 1.22 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bellus Health's market, we take the total number of its shares issued and multiply it by Bellus Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Bellus Profitablity

Bellus Health's profitability indicators refer to fundamental financial ratios that showcase Bellus Health's ability to generate income relative to its revenue or operating costs. If, let's say, Bellus Health is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Bellus Health's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Bellus Health's profitability requires more research than a typical breakdown of Bellus Health's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2022
Return on Average Assets(0.41) (0.44) 
Return on Average Equity(0.45) (0.48) 
Return on Invested Capital(0.71) (0.76) 
Return on Sales-4.5 K-4.6 K

Management Efficiency

The entity has Return on Asset of (20.9) % which means that on every $100 spent on asset, it lost $20.9. This is way below average. In the same way, it shows return on shareholders equity (ROE) of (33.82) %, meaning that it generated no profit with money invested by stockholders. Bellus Health management efficiency ratios could be used to measure how well bellus health manages its routine affairs as well as how well it operates its assets and liabilities. Return on Average Assets is likely to drop to -0.44 in 2022. Return on Average Equity is likely to drop to -0.48 in 2022. Bellus Health Total Liabilities is comparatively stable at the moment as compared to the past year. Bellus Health reported Total Liabilities of 17.57 Million in 2021. Current Liabilities is likely to gain to about 18.3 M in 2022, whereas Liabilities Non Current is likely to drop slightly above 514.8 K in 2022.
Last ReportedProjected for 2022
Book Value per Share 3.73  3.83 
Enterprise Value over EBIT(11.00) (11.87) 
Enterprise Value over EBITDA(10.98) (11.85) 
Price to Book Value 2.76  2.69 
Tangible Assets Book Value per Share 3.95  4.05 
Enterprise Value610.5 M658.8 M
Tangible Asset Value309.6 M334 M

Technical Drivers

As of the 15th of August 2022, Bellus Health shows the Risk Adjusted Performance of 0.2564, downside deviation of 4.63, and Mean Deviation of 3.72. Bellus Health technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down and interpolate nineteen technical drivers for Bellus Health, which can be compared to its rivals. Please confirm Bellus Health downside deviation, jensen alpha, as well as the relationship between the Jensen Alpha and downside variance to decide if Bellus Health is priced correctly, providing market reflects its regular price of 11.93 per share. Given that Bellus Health has jensen alpha of 0.8938, we suggest you to validate Bellus Health's prevailing market performance to make sure the company can sustain itself at a future point.

Bellus Health Price Movement Analysis

The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Mid-point Price over period is an average of Bellus Health highest and lowest prices attained during the given period.
.

Bellus Health Predictive Daily Indicators

Bellus Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Bellus Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Bellus Health Forecast Models

Bellus Health time-series forecasting models is one of many Bellus Health's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bellus Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Bellus Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Bellus Health stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bellus shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Bellus Health. By using and applying Bellus Stock analysis, traders can create a robust methodology for identifying Bellus entry and exit points for their positions.
Last ReportedProjected for 2022
EBITDA Margin(9.56) (10.31) 
Gross Margin 0.90  0.89 
Profit Margin(10.22) (11.03) 
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough and other cough hypersensitivity indications. The company was incorporated in 1993 and is based in Laval, Canada. Bellus Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 40 people.

Current Bellus Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Bellus analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Bellus analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
13.69Buy8Odds
Bellus Health current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Bellus analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Bellus stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Bellus Health, talking to its executives and customers, or listening to Bellus conference calls.
Bellus Analyst Advice Details

Bellus Stock Analysis Indicators

Bellus Health stock analysis indicators help investors evaluate how Bellus Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Bellus Health shares will generate the highest return on investment. By understating and applying Bellus Health stock analysis, traders can identify Bellus Health position entry and exit signals to maximize returns.
Quick Ratio14.75
Fifty Two Week Low2.95
Shares Short Prior Month12.75M
Average Daily Volume Last 10 Day1.04M
Average Daily Volume In Three Month1.09M
Shares Percent Shares Out14.55%
Gross Margins100.00%
Forward Price Earnings-14.75
Float Shares72.38M
Fifty Two Week High12.69
Fifty Day Average9.40
Two Hundred Day Average7.62
Enterprise Value To Revenue50,879.56
Continue to Trending Equities. Note that the Bellus Health information on this page should be used as a complementary analysis to other Bellus Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Complementary Tools for Bellus Stock analysis

When running Bellus Health price analysis, check to measure Bellus Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bellus Health is operating at the current time. Most of Bellus Health's value examination focuses on studying past and present price action to predict the probability of Bellus Health's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bellus Health's price. Additionally, you may evaluate how the addition of Bellus Health to your portfolios can decrease your overall portfolio volatility.
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Is Bellus Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bellus Health. If investors know Bellus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bellus Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
1.5 B
Return On Assets
-0.22
Return On Equity
-0.37
The market value of Bellus Health is measured differently than its book value, which is the value of Bellus that is recorded on the company's balance sheet. Investors also form their own opinion of Bellus Health's value that differs from its market value or its book value, called intrinsic value, which is Bellus Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bellus Health's market value can be influenced by many factors that don't directly affect Bellus Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bellus Health's value and its price as these two are different measures arrived at by different means. Investors typically determine Bellus Health value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bellus Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.